Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.verified

TALS

Price:

$2.72

Market Cap:

$116.44M

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immu...[Read more]

Industry

Biotechnology

IPO Date

2021-05-07

Stock Exchange

NASDAQ

Ticker

TALS

The Dividend Yield as of November 2024 (TTM) for Talaris Therapeutics, Inc. (TALS) is 0%

According to Talaris Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Talaris Therapeutics, Inc. (TALS) Historical Dividend Yield (quarterly & annually)

How has TALS Dividend Yield performed in the past?

The mean historical Dividend Yield of Talaris Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), TALS's Dividend Yield was at its highest in in the March 2020 quarter at 0%. The Dividend Yield was at its lowest in in the March 2020 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Talaris Therapeutics, Inc. (TALS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Talaris Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20220%0%
20210%0%
20200%0%

Talaris Therapeutics, Inc. (TALS) Average Dividend Yield

How has TALS Dividend Yield performed in the past?

The current Dividend Yield of Talaris Therapeutics, Inc. (TALS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Talaris Therapeutics, Inc. (TALS) Dividend Yield vs. Peers

How is TALS’s Dividend Yield compared to its peers?

Talaris Therapeutics, Inc.’s Dividend Yield is less than Edgewise Therapeutics, Inc. (0%), less than Adicet Bio, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Vor Biopharma Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Instil Bio, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Nuvation Bio Inc. (0%), less than Achilles Therapeutics plc (0%), less than NextCure, Inc. (0%), less than Ovid Therapeutics Inc. (0%), less than Connect Biopharma Holdings Limited (0%),

Build a custom stock screener for Talaris Therapeutics, Inc. (TALS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Talaris Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Talaris Therapeutics, Inc. (TALS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Talaris Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Talaris Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Talaris Therapeutics, Inc. (TALS)?

What is the highest Dividend Yield for Talaris Therapeutics, Inc. (TALS)?

What is the 3-year average Dividend Yield for Talaris Therapeutics, Inc. (TALS)?

What is the 5-year average Dividend Yield for Talaris Therapeutics, Inc. (TALS)?

How does the current Dividend Yield for Talaris Therapeutics, Inc. (TALS) compare to its historical average?